Related Experiment Video
Updated: Jun 19, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Rasmussen's encephalitis: update on pathogenesis and treatment
Pia Bernasconi1, Carlo Antozzi, Tiziana Granata
1Istituto Nazionale Neurologico Carlo Besta, via Celoria 11, 20133 Milan, Italy. pbernasconi@istituto-besta.it
Abstract:
Rasmussen's encephalitis is a devastating disease characterized by refractory epilepsy and progressive atrophy of one cerebral hemisphere. The only treatment option able to prevent seizures is the surgical disconnection of the affected hemisphere. The etiology of the disease remains unknown, but several laboratory findings have recently indicated the involvement of the immune system. Whether these findings represent an initiating event or the consequence of a not yet identified trigger factor must be elucidated. Nevertheless, these observations suggest the use of different immunomodulatory approaches (including corticosteroids, plasmapheresis, intravenous immunoglobulins and immunosuppressive drugs) that proved to be of variable efficacy in some patients, confirming the potential role of the immune system, at least in the perpetuation of the disease.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Bacterial Meningitis II: Pathophysiology
Rocky Mountain Spotted Fever
Arboviral Encephalitis
Bacterial Meningitis I: Introduction